Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, replacing the study content with a simple error layout and a Home button. The detailed study information and navigation are no longer visible due to access restrictions.
    Difference
    16%
    Check dated 2026-09-19T19:21:58.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The study record now includes information about sharing individual participant data (IPD), including policy details, the plan for IPD sharing, and a URL for the policy.
    Difference
    0.4%
    Check dated 2026-09-12T18:03:45.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A funding line for 2019 (U.S. NIH Grant/Contract) has been added. The revision history now shows Revision: v3.6.6, replacing the previous v3.6.5 entry.
    Difference
    0.0%
    Check dated 2026-08-29T18:56:30.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The input indicates no changes to add or remove on the page; thus the page content remains as currently published.
    Difference
    0.0%
    Check dated 2026-08-22T16:27:09.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new Publication entry was added under Publications: Armstrong AW, Lebwohl M, Warren RB, Morita A, Paul C, Thaci D, Augustin M, Puig L, Daamen C, Li J, Alio A, Aggrey-Amable A, Scotto J, Popmihajlov Z, Vaile J, Strober B. Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials, Am J Clin Dermatol, 2026 Aug 7 (online ahead of print).
    Difference
    0.0%
    Check dated 2026-08-15T12:15:29.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a minor update to the page's metadata/documentation. This appears to be a routine version bump rather than a change to study content or patient-facing information.
    Difference
    0.0%
    Check dated 2026-08-08T08:56:24.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.